Expression and regulation of CCN genes in murine osteoblasts

Bone

Volumn 38, Issue 5, 2006, Pages 671-677

  Parisi, Muriel S ^a   Gazzerro, Elizabetta ^a,b   Rydziel, Sheila ^a   Canalis, Ernesto ^a,b  

^a SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Bone formation; Bone morphogenetic proteins; CCN genes; Glucocorticoids; Transforming growth factor

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CONNECTIVE TISSUE GROWTH FACTOR; CYSTEINE RICH PROTEIN 61; HYDROCORTISONE; MESSENGER RNA; NEPHROBLASTOMA OVEREXPRESSED PROTEIN; REGULATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT INDUCED SECRETORY PROTEIN 1; WNT INDUCED SECRETORY PROTEIN 2; WNT INDUCED SECRETORY PROTEIN 3;

ANIMAL CELL; ARTICLE; CELL ASSAY; CELL CULTURE; CELL NUCLEUS; CONTROLLED STUDY; EXAMINATION; GENE EXPRESSION REGULATION; GENE REPRESSION; GENETIC TRANSCRIPTION; MOUSE; NEWBORN; NONHUMAN; NORTHERN BLOTTING; OSTEOBLAST; PROTEIN DETERMINATION; PROTEIN INDUCTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CELLS, CULTURED; GENE EXPRESSION REGULATION; HYDROCORTISONE; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; OSTEOBLASTS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 33646102224     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2005.10.005     Document Type: Article

References (43)

1. Brigstock D.R., Goldschmeding R., Katsube K.I., Lam S.C., Lau L.F., Lyons K., et al. Proposal for a unified CCN nomenclature. J. Clin. Pathol. Mol. Pathol. 56 (2003) 127-128
2. Bork P. The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett. 327 (1993) 125-130
3. Brigstock D.R. The CCN family: a new stimulus package. J. Endocrinol. 178 (2003) 169-175
4. Laurent M., Martinerie C., Thibout H., Hoffman M.P., Verrecchia F., Le Bouc Y., et al. NOVH increases MMP3 expression and cell migration in glioblastoma cells via a PDGFR-α-dependent mechanism. FASEB J. 17 (2003) 1919-1921
5. Abreu J.G., Coffinier C., Larrain J., Oelgeschlager N., and DeRobertis E.M. Chordin-like CR domains and the regulation of evolutionary conserved extracellular signaling systems. Gene 287 (2002) 39-47
6. Abreu J.G., Keptura N.I., Reversada B., and De Robertis E.M. Connective-tissue growth factor (CTGF) modulates cell signaling by BMP and TGF-β. Nat. Cell Biol. 4 (2002) 599-604
7. Mercurio S., Latinkic B., Itasaki N., Krumlauf R., and Smith J.C. Connective-tissue growth factor modulates WNT signaling and interacts with the WNT receptor complex. Development 131 (2003) 2137-2147
8. Jedsadayanmata A., Chen C.C., Kireeva M.L., Lau L.F., and Lam S.C. Activation-dependent adhesion of human platelets to Cyr61 and Fisp12/mouse connective tissue growth factor is mediated through integrin alpha (IIb) beta (3). J. Biol. Chem. 274 (1999) 24321-24327
9. Babic A.M., Chen C.C., and Lau L.F. Fisp 12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin αvβ3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol. Cell. Biol. 19 (1999) 2958-2966
10. Shimo T., Nakanishi T., Nishida T., Asano M., Kanyama M., Kuboki T., et al. Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo. J. Biochem. 126 (1999) 137-145
11. 3 and α5β1. J. Vasc. Res. 40 (2003) 234-243
12. Lin C.G., Chen C., Leu S., Grzeszkiewicz T.M., and Lau L.F. Integrin-dependent functions of the angiogenic inducer NOV (CCN3): implications in wound healing. J. Biol. Chem. 280 (2005) 8229-8237
13. Hadjiargyrou M., Ahrens W., and Rubin C.T. Temporal expression of the chondrogenic and angiogenic growth factor CYR61 during fracture repair. J. Bone Miner. Res. 15 (2000) 1014-1023
14. Nishida T., Nakanishi T., Asano M., Shimo T., and Takigawa M. Effects of CTGF/Hcs24, a hypertrophic chondrocyte-specific gene product, on the proliferation and differentiation of osteoblastic cells in vitro. J. Cell. Physiol. 184 (2000) 197-206
15. Ivkovic S., Yoon B.S., Popoff S.N., Safadi F.F., Libuda D.E., Stephenson R.C., et al. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 130 (2003) 2779-2791
16. Sakamoto K., Yamaguchi S., Ando R., Miyawaki A., Kabasawa Y., Takagi M., et al. The nephroblastoma overexpressed gene (NOV/ccn3) protein associates with Notch1 extracellular domain and inhibits myoblast differentiation via Notch signaling pathway. J. Biol. Chem. 277 (2002) 29399-29405
17. Sciaudone M., Gazzerro E., Priest L., Delany A.M., and Canalis E. Notch 1 impairs osteoblastic cell differentiation. Endocrinology 144 (2003) 5631-5639
18. French D.M., Kaul R.J., D'Souza A.L., Crowley C.W., Bao M., Frantz G.D., et al. WISP-1 is an osteoblastic regulator expressed during skeletal development and fracture repair. Am. J. Pathol. 165 (2004) 855-867
19. Hurvitz J.R., Suwairi W.M., Van Hul W., El-Shanti H., Superti-Furga A., Roudier J., et al. Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia. Nat. Genet. 23 (1999) 94-98
20. Pereira R.C., Durant D., and Canalis E. Transcriptional regulation of connective tissue growth factor by cortisol in osteoblasts. Am. J. Physiol. 279 (2000) E570-E576
21. Margolis R.N., Canalis E., and Partridge N.C. Anabolic hormones in bone: basic research and therapeutic potential. J. Clin. Endocrinol. Metab. 81 (1996) 872-877
22. Canalis E., Economides A.E., and Gazzerro E. Bone morphogenetic proteins, their antagonists and the skeleton. Endocr. Rev. 24 (2003) 218-235
23. Canalis E., Bilezikian J.P., Angeli A., and Giustina A. Perspectives on glucocorticoid induced osteoporosis. Bone 34 (2004) 593-598
24. McCarthy T.L., Centrella M., and Canalis E. Further biochemical and molecular characterization of primary rat parietal bone cell cultures. J. Bone Miner. Res. 3 (1988) 401-408
25. Greenberg M.E., and Ziff E.B. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature 311 (1984) 433-438
26. Nazarenko I., Lowe B., Darfler M., Ikonomi P., Schuster D., and Rashtchian A. Multiplex quantitative PCR using self-quenched primers labeled with a single fluorophore. Nucleic Acids Res. 30 (2002) e37
27. Laemmli U.K. Cleavage of structural proteins during the assembly of the head bacteriophage T4. Nature 277 (1970) 680-685
28. Schutze N., Noth U., Schneidereit J., Hendrich C., and Jakob F. Differential expression of CCN-family members in primary human bone marrow-derived mesenchymal stem cells during osteogenic, chondrogenic and adipogenic differentiation. Cell Commun. Signal 3 1 (2005) 5
29. Boes M., Dake B.L., Booth B.A., Erondu N.E., Oh Y., Hwa V., et al. Connective tissue growth factor (IGFBP-rP2) expression and regulation in cultured bovine endothelial cells. Endocrinology 140 (1999) 1575-1580
30. Grotendorst G.R., Okochi H., and Hayashi N. A NOVel transforming growth factor β response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ. 7 (1996) 469-480
31. Yang D.H., Kim H.S., Wilson E.M., Rosenfeld R.G., and Oh Y. Identification of glycosylated 38-kDa connective tissue growth factor (IGFBP-related protein 2) and proteolytic fragments in human biological fluids, and up-regulation of IGFBP-rP2 expression by TGF-β in Hs578T human breast cancer cells. J. Clin. Endocrinol. Metab. 83 (1998) 2593-2596
32. Lafont J., Laurent M., Thibout H., Lallemand F., Le Bouc Y., Atfi A., et al. The expression of NOVH in adrenocortical cells is down-regulated by TGFβ 1 through c-Jun in a Smad-independent manner. J. Biol. Chem. 277 (2002) 41220-41229
33. Lau L.F., and Lam S.C. The CCN family of angiogenic regulators: the integrin connection. Exp. Cell Res. 248 (1999) 44-57
34. Joliot V., Martinerie C., Dambrine G., Plassiart G., Brisoc M., Crochet J., and Perbal B. Proviral rearrangements and overexpression of a new cellular gene (NOV) in myeloblastosis-associated virus type-1 induced nephroblastomas. Mol. Cell. Biol. 12 (1992) 10-21
35. Latinkic B.V., Mercurio S., Bennet B., Hirst E.M.A., Xu Q., Lau L.F., et al. Xenopus Cyr61 regulates gastrulation movements and modulates Wnt signaling. Development 130 (2003) 2429-2441
36. Luo Q., Kang Q., Si W., Jiang W., Park J.K., Peng Y., et al. Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells. J. Biol. Chem. 279 (2004) 55958-55968
37. Fu C.T., Bechberger J.F., Ozog M.A., Perbal B., and Naus C.C. CCN3 (NOV) interacts with Connexin 43 in C6 glioma cells: possible mechanism of connexin-mediated growth suppression. J. Biol. Chem. 279 (2004) 36943-36950
38. Gazzerro E., Pereira R.C., Jorgetti V., Olson S., Economides A.N., and Canalis E. Skeletal overexpression of gremlin impairs bone formation and causes osteopenia. Endocrinology 146 (2005) 655-665
39. Winkler D.G., Sutherland M.S., Ojala E., Turcott E., Geoghegan J.C., Shpektor D., et al. Sclerostin inhibition of Wnt-3a-induced C3H10T1/2 cell differentiation is indirect and mediated by bone morphogenetic proteins. J. Biol. Chem. 280 (2005) 2498-2502
40. Ohnaka K., Taniguchi H., Kawate H., Nawata H., and Takayanagi R. Glucocorticoid enhances the expression of dickkopf-1 in human osteoblasts: NOVel mechanism of glucocorticoid-induced osteoporosis. Biochem. Biophys. Res. Commun. 318 (2004) 259-264
41. Wang F.S., Lin C.L., Chen Y.J., Wang C.J., Yang K.D., Huang Y.T., et al. Secreted frizzled-related protein 1 modulates glucocorticoid attenuation of osteogenic activities and bone mass. Endocrinology 146 (2005) 2415-2423
42. Smith E., and Frendel B. Glucocorticoids inhibit LEF/TCF transcriptional activity in differentiating osteoblasts in a GSK3β-dependent and independent manner. J. Biol. Chem. 280 (2005) 2388-2394
43. Ohnaka K., Tanabe M., Kawate H., Nawata H., and Takayanagi R. Glucocorticoid suppresses the canonical Wnt signal in cultured human osteoblasts. Biochem. Biophys. Res. Commun. 329 (2005) 177-181